|View printer-friendly version|
|March 27, 2005 11:06 a.m.|
|Teva Announces Tentative Approval Of Amlodipine Besylate Tablets|
Jerusalem, Israel, March 27, 2005 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Amlodipine Besylate Tablets, 2.5 mg, 5 mg and 10 mg. Final approval is expected upon expiration of patent protection on September 25, 2007.